EarliPoint Health
PrivateLast Round
Seed Round
Apr 15, 2026
Total Funding Raised
$41M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EarliPoint Health operates in Healthcare & Life Sciences and is based in Plymouth, Minnesota. Its latest recorded funding round was a Series B round in April 2024.
EarliPoint Health is a medical device company that develops diagnostic and therapeutic solutions for children with autism spectrum disorder and related early childhood vulnerabilities.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EarliPoint Health Comparables
Compare EarliPoint Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognoa | 87% | |
| BlinkLab Limited | 76% | |
| LinusBio | 72% |
For institutional investors. Book with your work email.
EarliPoint Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 15, 2026 | ||||
| Series B | Apr 2, 2024 | ||||
| Series A | Feb 18, 2022 |
For institutional investors. Book with your work email.
EarliPoint Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nexus NeuroTech Ventures | Series B |
| Georgia Research Alliance | Series A |
| Venture Investors Health Fund | Series B |
| Georgia Research Alliance | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Open roles increased from 0 to 23, representing 61% of headcount.
- May 21, 2026
Monthly visitors increased 50% MoM.
For institutional investors. Book with your work email.
EarliPoint Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EarliPoint Health's valuation, stock price, and market status.
Is EarliPoint Health a public or private company?
EarliPoint Health is a private company.
What is the current stock price of EarliPoint Health?
EarliPoint Health is a private company, so its shares have no public market price. Caplight tracks EarliPoint Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EarliPoint Health worth (valuation)?
Valuation information for EarliPoint Health is not publicly available.
Can I buy EarliPoint Health stock?
EarliPoint Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EarliPoint Health's last funding round?
EarliPoint Health's most recent funding round was Seed Round on April 15, 2026.
Who are the main investors in EarliPoint Health?
Key investors in EarliPoint Health include Nexus NeuroTech Ventures, Venture Investors Health Fund, Georgia Research Alliance.
Will EarliPoint Health IPO soon?
No public IPO plans have been announced for EarliPoint Health.
How can I track EarliPoint Health secondary market activity?
Caplight tracks bids, offers, and trades in EarliPoint Health's shares on secondary markets.